PR Newswire | Oct 23, 2020 04:44PM EDT

Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited

10/23 15:44 CDT

Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited NEW YORK, Oct. 23, 2020

NEW YORK, Oct. 23, 2020 /PRNewswire/ --

American Renal Associates Holdings, Inc. (NYSE: ARA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ARA to affiliates of Nautic Partners for $11.50 per share.

If you are a ARA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

BMC Stock Holdings, Inc. (NASDAQ: BMCH) - Builders FirstSource, Inc. (NASDAQ: BLDR)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BMCH to Builders FirstSource, Inc.

If you are a BMCH or BLDR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management.

If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form.

CIT Group Inc. (NYSE: CIT)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CIT to First Citizens BancShares, Inc. for 0.0620 shares of First Citizens class A common stock per share.

Eidos Therapeutics, Inc. (NASDAQ: EIDX) - BridgeBio Pharma, Inc. (NASDAQ: BBIO)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of EIDX to BridgeBio Pharma for approximately $73.26 per share.

If you are a EIDX or BBIO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

MyoKardia, Inc. (NASDAQ: MYOK)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of MYOK to Bristol-Myers Squibb for $225.00 per share.

If you are a MYOK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Watford Holdings Ltd. (NASDAQ: WTRE)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of WTRE to Arch Capital Group Ltd. for $31.10 per share.

If you are a WTRE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Yintech Investment Holdings Limited (NASDAQ: YIN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of YIN to members of YIN management.

If you are a YIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.(c) 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.Lifshitz Law Firm, P.C. Phone: 516-493-9780Facsimile: 516-280-7376Email:info@jlclasslaw.com

View original content: http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-american-renal-associates-holdings-inc-bmc-stock-holdings-inc-builders-firstsource-inc-cellular-biomedicine-group-inc-cit-group-inc-eidos-therapeutics-inc-myokard-301159036.html

SOURCE Lifshitz & Miller Law Firm